TRIB
Trinity Biotech
TRIB
TRIB
21 hedge funds and large institutions have $7.5M invested in Trinity Biotech in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $8.92M → $7.5M (-$1.43M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
21
Holding in Top 10
–
Calls
$21K
Puts
$15K
Top Buyers
| 1 | +$16K | |
| 2 | +$10K | |
| 3 | +$2.57K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.12K |
Top Sellers
| 1 | -$217K | |
| 2 | -$69.7K | |
| 3 | -$14K | |
| 4 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
-$12.1K |
| 5 |
AC
Aristides Capital
Louisville,
Kentucky
|
-$9.82K |